BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Topiramate: Data concerning the risk of malformations

Active substance: topiramate

Based on evaluations from pregnancy registries, the USA has now also revised the product informations of medicinal products containing topiramate and has included corresponding warnings already implemented in European marketing authorisations.

risk information - full text (available in German only)